Monthly Archives September 2021

Best Debt Consolidation Loans for October 2021 – Forbes Advisor

By Posted on 0 Comments2min read1 views

Upstart has established itself in the field of personal loans because of its approach based on artificial intelligence and machine learning for qualifying borrowers. In fact, Upstart estimates that it was able to approve 27% more borrowers than possible under a traditional lending model. With competitive APRs, Upstart is not a leading lender for borrowers who can benefit from more competitive rates. Even so, the platform’s minimum credit score of 600 makes it an accessible option for those with fair credit.

Upstart also offers a fairly flexible range of loan options, with amounts ranging from as low as $ 1,000, so you don’t have to borrow (or pay interest) more than you really need. And, while Upstart’s loans cap at $ 50,000, which is less than some lenders, that will likely be enough for many potential borrowers.

Even though Upstarts’ three- and five-year loan terms are more restrictive than those of other lenders, this is likely an acceptable compromise for applicants who might not be approved in a more traditional lending environment. Plus, it’s available in all states except West Virginia and Iowa, so it’s as widely available as many other top lenders.

Eligibility: Upstart stands out because it uses an AI-powered platform to take into account a range of unconventional variables when assessing borrower applications. And, although the platform advertises a minimum credit score of 600, Upstart can even accept applicants who don’t have enough credit history to get a score. When assessing potential borrowers, Upstart takes into account college education, employment history, residency, debt-to-income ratio, bankruptcies and defaults, and number of credit applications.

Borrowers must also have a full-time job or an offer starting in six months, a regular part-time job or other regular source of income, with a minimum annual income of $ 12,000. Co-signers and co-applicants are not allowed.

Uses of the loan: Upstart personal loans can be used for credit card and other debt consolidation, special events, moving and relocation, medical and dental expenses, and home renovations. Unlike many other traditional and online lenders, Upstart also allows borrowers to use personal loan funds to cover education expenses (except in California, Connecticut, Illinois, Washington and D.C. District of Columbia).

Successful borrowers cannot use personal loans to finance illegal activities or purchase illegal weapons, firearms, or drugs.

Completion time : Upstart provides next business day financing to borrowers whose loans are accepted before 5:00 p.m. Eastern Time, Monday through Friday. Loans approved after 5:00 p.m. are usually funded the next business day or day. That said, Upstart reports that 99% of loan seekers receive their money within a business day after agreeing to their loan terms. Loans for education expenses can take up to three additional business days after loan acceptance.

Source link

BoT adds guidelines for debt consolidation

By Posted on 0 Comments2min read1 views

BoT adds guidelines for debt consolidation

Move aims to reduce interest burden

The Bank of Thailand (BoT) plans to implement additional guidelines for the debt consolidation program to help retail loan borrowers reduce interest rate charges.

The BoT has prepared additional debt assistance options to help borrowers ease their debt burden amid the latest protracted Covid-19 outbreak.

The central bank is expected to implement the new guidelines for the current retail loan consolidation program in October, said Chayawadee Chai-Anant, senior director of the BoT’s economic and policy department.

The central bank offers debt consolidation as an option as part of its debt restructuring program for personal loans.

Under the current concept of debt consolidation, retail loan borrowers can consolidate all consumer loan debt from many financial institutions into one bank for refinancing purposes and can convert that debt by swapping out non-loans. short term secured in long term loans in order to receive lower interest rates.

As part of the additional orientations of the debt consolidation program, the central bank will set the ceiling rates for this mutualized debt, added Ms. Chayawadee.

For example, the ceiling rate for debt consolidation between personal loans and mortgages should not exceed 10% per annum.

Currently, mortgage interest rates are based on the Minimum Retail Rate (MRR) or Minimum Lending Rate (MLR) for home loans of around 6-8% per annum, while the interest rate maximum for personal loans is 25% per annum.

In addition, the central bank will require lenders to waive prepayment fees for debt consolidation.

“Debt consolidation will encourage competitive mechanisms in the market and benefit borrowers, especially in terms of lowering interest rates. Therefore, it will further help borrowers to ease the debt burden,” he said. she declared.

The central bank relaxed, adjusted and implemented additional debt relief measures for both existing debt restructuring and new loan offerings.

These will help borrowers, especially individuals and small and medium-sized businesses, to reduce their debt.

In view of the protracted epidemic, the central bank has focused on restructuring long-term debt rather than a moratorium on short-term debt.

Borrowers participating in the debt relief measures represented 5.12 million accounts, representing a total outstanding loan of 3.35 trillion baht.

Source link

Debt Consolidation Loans: Compare The Best Lenders

By Posted on 0 Comments4min read2 views

Debt Consolidation Loans: What You Need To Know

What is a debt consolidation loan and how does it work?

A debt consolidation loan is a single loan that you use to pay off multiple debts, such as high interest credit card balances, medical bills, or other unsecured debt. This strategy can reduce the total interest you owe on the debt and help you pay it off faster.

Online lenders, some banks, and credit unions offer debt consolidation loans. If you qualify, the lender deposits the loan into your bank account and you use that money to pay off your debts. Some lenders will send your loan proceeds directly to your creditors, saving you this step.

Once you have paid off your other debts, you make monthly payments for the debt consolidation loan. Payments are fixed for the life of the loan, typically two to seven years.

Debt consolidation is one of the strategies of pay off the debt. Debt consolidation won’t work if you have too much debt or haven’t addressed the underlying spending issues.

How Do I Qualify For A Debt Consolidation Loan?

Almost all lenders require that you be 18 years of age or older, a legal resident of the United States with a verifiable bank account and not in bankruptcy or foreclosure.

Borrowers with good or excellent credit (690 or more on the FICO scale) and poor debt / income ratios may qualify for lower interest rates. Strong credit can also qualify you for larger loan amounts.

Someone with bad or fair credit (689 or less on the FICO scale) and a stable income may still qualify, but would likely see a higher interest rate. It may be worthwhile to shop around and compare the rates of debt consolidation loans to find the most affordable.

What rate should I expect?

Debt consolidation loans work best if the loan has a lower interest rate than the combined interest of your existing debts. You can use NerdWallet debt consolidation calculator to see your total balance, total monthly payment, and your combined debt interest rate.

Rates vary from lender to lender and are highly dependent on your credit history and ability to repay. Here is what interest rate on personal loans looks on average like:

25.3% (lower scores are unlikely to qualify).

Source: Average rates are based on aggregated and anonymized supply data of users who prequalified in the NerdWallet lender market from July 1, 2020 through July 31, 2021. Rates are estimates only and are not intended for use. specific to any lender.

How Will Debt Consolidation Affect My Credit Rating?

Lenders will do a credit check when you apply for a debt consolidation loan. This temporarily lowers your credit score by a few points and will stay on your credit report for two years.

Like other forms of credit, making your monthly loan payment on time and in full helps you build credit, while missing payments could damage it.

If you took out the loan to pay off credit card debt but end up having a balance on your cards while the loan is still active, your credit score could suffer.

As long as you are able to pay off your loan and stay out of debt, consolidation could have an overall positive effect on your credit.

Debt Consolidation vs Balance Transfer Card

For borrowers with good credit, a credit card balance transfer is an alternative to debt consolidation loan. These cards have an introductory interest rate of 0%, which increases after a promotional period, typically no longer than 18 months.

You will want to pay off the card balance before the introductory period expires, as your card’s regular interest rate will then go into effect. In addition to paying off your balance before the rate increases, you’ll want to avoid charging other fees.

Unlike balance transfer cards, borrowers of all credit categories may be eligible for a personal loan, although rates vary. Fixed payments on a personal loan also ensure that you will pay off your debts on a set schedule. And while a card issuer will decide your credit limit on a balance transfer card, personal loan borrowing limits are generally high, with some lenders offering loans of $ 50,000 or more.

A personal loan balance is reported as installment debt, which is treated differently in credit scoring formulas than revolving debt such as credit cards. Revolving debt has a bigger impact on your score, so paying off a balance transfer card could help you build credit faster.

How to choose a debt consolidation loan

Choosing the right debt consolidation loan will depend on your credit score, income, desired loan amount, and repayment term, but it’s a good rule of thumb to look for the lowest. annual percentage rate.

Many online lenders will allow you prequalified to compare rates, which will not hurt your credit score. This feature is less common among banks and credit unions.

You should also look for lenders who specialize in debt consolidation or offer benefits such as sending your loan funds directly to your creditors, reporting payments to the three major credit bureaus, and providing financial education. free.

NerdWallet has reviewed over 30 lenders to help you choose the right one for you. Below is a list of lenders that stand out debt consolidation loans.

How to manage my debt consolidation loan

As you progress through your loan repayment, keep your credit card balance at zero until you are debt free. But try not to close your accounts, which can lower your credit score. Some creditors may require you to pay a fee to keep your account open.

Source link

Deep learning improves cancer diagnostic tools

Yi “Edwin” Sun, Ph.D. Electrical and Computer Engineering candidate at the University of Illinois Urbana-Champaign and a member of the Beckman Institute Biophotonic Imaging Lab led by Stephen Boppart, explored how deep learning methods can render optical coherence tomography polarization sensitive, or PS-OCT, more expensive. efficient and better equipped to diagnose cancer in biological tissues.

The article, titled “Synthetic polarization-sensitive Optical Coherence Tomography by Deep Learning”, was published in npj Digital Medicine.

OCT systems are common in the clinic and are used to generate high resolution cross sectional images of areas of the human body. Sun and his team have developed a revolutionary method of software application to the OCT tool to provide polarization-sensitive capabilities, without the cost and complexity that come with hardware-based PS-OCT imaging systems.

“We are trying to replace the hardware associated with the PS-OCT,” Sun said. “Nevertheless, [it] is still in the development and research stage. By adding a deep learning model on top of an OCT system, we suddenly come to PS-OCT capabilities without the traditional hardware added.

OCT is a non-invasive imaging test that uses light waves to determine the properties of a biological sample. However, by allowing the tool to use polarization sensitivity, scientists can detect relevant information that OCT cannot capture on its own. For example: OCT can differentiate tissues in a precise way and when the broader characteristics are clear; PS-OCT can detect abnormalities at a deeper level, differentiating microstructural features such as the orientations of collagen fibers that change in a cancer-infected area compared to a normal area.

“We have proven that applying our method to other systems can generate PS-OCT contrast, and that this model can be used on many OCT systems to help us differentiate between cancerous tissue and other types of tissue. tissues much better than OCT systems alone, ”Sun said. . “It’s a huge improvement, which makes this system better for cancer diagnoses.”

Deep learning, a subset of machine learning, has enabled the Sun team to create software that can be combined with OCT systems to provide polarization sensitivity.

“Deep learning has enabled a more advanced method of detecting subtle features in images, which can be used for more precise segmentation and classification. It also allows the imaging tool to use multiple layers to capture spatial features in an image, ”Sun said.

By applying historical data, deep learning methods aid in accurate diagnoses and even medical predictions. Sun’s team tested their model by predicting what a photo of a lush summer forest in December might look like: barren, gray, maybe a bit of ice and snow in the trees. With this concept in mind, images from OCT systems, coupled with this deep learning approach, can even predict the PS-OCT images that would come from more complex and expensive PS-OCT systems.

“Edwin’s study really highlights the power and potential of AI and deep learning approaches to predict and generate synthetic PS-OCT images from standard OCT images, a type of translation from image to image. With the increasing use of OCT in medical fields, this advancement is likely to have a broad impact and ultimately help improve disease detection and diagnosis, ”said Boppart, Ph.D. of Sun. thesis director who is both a doctor and a professor of engineering at the UIUC.

This research was funded in part by grants from the National Cancer Institute and the National Institutes of Health.

Reference: Sun Y, Wang J, Shi J, Boppart SA. Deep learning polarization sensitive synthetic optical coherence tomography. npj Average number. 2021; 4 (1): 1-7. doi: 10.1038 / s41746-021-00475-8

This article was republished from the following materials. Note: The material may have been modified for its length and content. For more information, please contact the cited source.

Source link

Molecular diagnostic tools help distinguish wild-type and vaccine strains of PRRSV

The porcine reproductive and respiratory syndrome virus (PRRSV) continues to challenge the US pork industry. The virus has become more difficult to control despite aggressive biosecurity methods, multiple commercial vaccines, live virus inoculation methods and the implementation of vaccination protocols, said Phillip Gauger, DVM, PhD, in a recent research article.1

Fortunately, there are several molecular diagnostic tests available to detect, sequence, and characterize PRRSV, said Gauger, a diagnostic pathologist in the Iowa State University Veterinary Diagnostic Laboratory and head of the molecular diagnostics section.

Challenges with SDRPV

“A particular challenge facing the industry has evolved through the use of modified live PRRSV vaccines (MLV-PRRSV) and the inability of diagnostic tests to distinguish between detection of wild-type PRRSV (WT -PRRSV) and / or vaccine type. strains of the virus, ”Gauger said.

“Vaccine-like MLV-PRRSV can replicate in vaccinated animals for long periods of time; is capable of transmission to unvaccinated pigs; can evolve genetically thanks to point mutations in the genome; and can undergo recombination with WT-PRRSV.

These factors can complicate the overall epidemiology or genetic ecology of PRRS, and several tests or sequencing tests may be required to distinguish between the presence of MLV-PRRSV or WT-PRRSV when mixed infections are suspected, a Gauger said.

New test options available

New molecular test methods have been developed to not only detect PRRSV in a sample, but also characterize the presence of different strains of PRRSV in a production system. These methods attempt to distinguish between detection of an MLV-PRRSV, WT-PRRSV or multiple strains of the virus, Gauger explained.

PRRS CLAMP refers to a molecular diagnostic sequencing tool that can help distinguish the presence of wild-type and vaccine strains of PRRSV.

“CLAMP is a term – not an acronym – to suggest what the test will do while it is running,” Gauger said. “Thus, it blocks the homologous sequence of an MLV-PRRSV and prevents the amplification and sequencing of this gene. CLAMP is the bridged nucleic acid designed to bind tightly to the homologous target, when present, and ultimately enables preferential sequencing of a WT-PRRSV.

There are many molecular diagnostic tests currently available to detect PRRS in pig diagnostic samples, Gauger said, but each has certain advantages and limitations (see box).

Promising future

Next-generation sequencing offers a range of processes that can provide the entire genome sequence of a specific virus, Gauger explained. It can also detect the presence of new viruses or allow in-depth sequencing of the microbiome.

“For routine diagnostic purposes, whole genome sequencing of PRRSV may be an appropriate option to answer a diagnostic question or monitor the epidemiology of a PRRSV circulating in a production system,” he said. declared.

“While no molecular diagnostic test is perfect, these tests and combinations of different tests improve the likelihood of detecting and characterizing one or more strains of PRRSV present in a group of pigs,” Gauger added.

“They also help reduce the risks associated with moving pigs unknowingly infected with WT-PRRSV, especially when MLV-PRRSV is present in the same population. “

Existing diagnostic tools

Real-time polymerase chain reaction (PCR) assay for PRRSV screening: These tests are very sensitive and can detect low concentrations of PRRSV and all strains. They are highly specific and multiplexed for PRRSV type 1 or type 2 species, but are not designed for further characterization of the virus nucleic acid and are not able to differentiate between different genetic strains of the virus, a Gauger said. If a PCR test for PRRSV is positive, additional testing may be necessary.

Sequencing of the PRRSV ORF5 gene: This test is a molecular diagnostic test based on the amplification of the ORF5 gene followed by the selective determination of the nucleotide sequence within the gene. “Diagnostic reports with the ORF5 sequence data will also include a comparison of nucleotide identity with the MLV-PRRSV vaccine strains,” Gauger said.

Real-time PCR by reverse transcription of the PRRSV vaccine type: “This assay can detect the presence of MLV-PRRSV and is suggested for use in PRRSV monitoring protocols in combination with other diagnostic assays (PRRSV-screen PCR and / or sequencing),” Gauger said. “Or, it can be used when the history, clinical impressions and use of the vaccine are well known to justify the use of this test,” Gauger said.

PRRSV CLAMP Sequencing Tests: This test is used when MLV-PRRSV and WT-PRRSV are suspected in a pig population. The CLAMP method uses a bridged nucleic acid as described above to prevent amplification and sequencing of MLV-PRRSV, allowing preferential sequencing and detection of WT-PRRSV, if present. It can detect lower concentration WT-PRRSV sequences in vaccinated pigs and helps reduce the risk of transmitting WT-PRRSV that could go undetected without the most advanced molecular tools currently available, Gauger said.

Source link

Seegene marks new milestone in popularization of molecular diagnostic technology

Seegene Inc., South Korea’s largest point-of-service diagnostic kit manufacturer, will mark another milestone in popularizing molecular diagnostic technology with an advanced polymerase chain reaction (PCR) machine in time. real to detect various viruses, including Covid variants in the clinical ward, helping authorities respond more quickly to the spread of the virus.

The new test called AIOS will be presented for the first time at the opening of the American Association for Clinical Chemistry (AACC) to be held in Atlanta from September 26 to 30, according to sources close to the company on Thursday.

The AACC houses the latest technology and information on various diagnostic equipment, reagents, and test methods. Seegene, whose annual sales reached $ 1 billion last year, is one of the most notable companies among this year’s AACC presenters.

According to the sources, AIOS can perform the entire process of molecular diagnostics, such as nucleic acid extraction, PCR testing, and reading of results, with one system after sample collection.

Depending on the type of reagents, AIOS can detect up to 10 types of viruses including Covid-19 variants at the same time, or up to 15 types of respiratory viruses except Covid viruses. It weighs about a third less than the bulky all-in-one PCR equipment that weighs 1 to 1.5 tonnes. The new equipment comes in the form of a separate set into two compact devices to allow transport and installation in small clinics.

Sales are expected to start worldwide at the start of the new year. Seegene will mark its 20th anniversary with the launch of AIOS which will make advanced molecular diagnostics available in most small and medium-sized hospitals and neighborhood clinics which account for 39% of patient beds compared to 9% of large hospitals in Korea, according to the sources.

By Kim Si-gyun and Minu Kim

[ⓒ Pulse by Maeil Business News Korea &, All rights reserved]

Source link

AI-Based Medical Diagnostic Tools Market Size, Growth, and Analysis by Major Key Players – Icometrix, Alivecor,, Aidoc – Stillwater Current

The latest recently published study, The forecast period of the global AI-based medical diagnostic tools market, 2021-2028. According to the study, the global AI-based medical diagnostic tools market was valued at XX USD and is projected to reach XX USD by 2027, exceeding only XX USD and an average of XX% per year during the period. forecast. This research report provides a comprehensive perspective of the market with detailed insights into drivers, restraints, opportunities, trends, and challenges, key factors that may affect targeted market results over the years.

The market reports provide a concise overview of the segments and sub-segments including product types, applications, players, and regions which provide key aspects of the market. The report focuses on the performance impact of the COVID-19 pandemic and provides the current market and takes an in-depth look at the market conditions. The report was able to conduct an in-depth study of market dynamics, changing consumer behavior, and flow of global supply chains affected by the market. This important information on reporting objectives provides clients with solid guidance in obtaining insight into their trading decisions from their investment market in order to assess factors that may affect current and future market conditions.

Competition analysis

This report provides a comprehensive view of the competitive environment for the AI-based medical diagnostic tools market and includes a detailed description of the performance of the major global players made in the market. It provides the latest updated list of several business strategies including mergers, acquisitions, partnerships, product launches, manufacturing unit expansions and collaborations adopted by these major global players. The report provides a clear picture of large companies’ R&D investments and adoption of innovative technologies to broaden their consumer base and extend their existing competitiveness. Furthermore, the report provides detailed information about the position of new entrants or players in the market, the extent of growth, and opportunities.

The research focuses on the current market size of the AI-based medical diagnostic tools market and its file-based growth rates with company outline of key players / manufacturers:

The Major Players Covered By AI-Based Medical Diagnostic Tools Markets:

  • Icometrix
  • Alivecor
  • Aidoc
  • IDx Technologies Inc.
  • Arteries inc.
  • Bay Labs
  • IA MaxQ
  • Ltd.
  • Zebra medical vision
  • Imagen Ltd
  • ScreenPoint Medical

AI-Based Medical Diagnostic Tools Market Segmentation:

The AI-based medical diagnostic tools market is split by type and by application. For the period 2021-2028, the cross-industry growth provides accurate calculations and sales forecast by type and application in terms of volume and value. This analysis can help you grow your business by targeting qualified niche markets.

AI-Based Medical Diagnostic Tools Market Split By Type:

  • Medical imaging tools
  • Automated detection systems
  • Others

AI-Based Medical Diagnostic Tools Market Split By Application:

  • Eye care
  • Oncology
  • Radiology
  • Cardiovascular
  • Pathology
  • Others (Orthopedics
  • Rare sickness)

Scope of the AI-Based Medical Diagnostic Tools Market Report

Report attribute Details
Market size available for years 2021 – 2028
Reference year considered 2021
Historical data 2015 – 2019
Forecast period 2021 – 2028
Quantitative units Revenue in millions of USD and CAGR from 2021 to 2027
Covered segments Types, applications, end users, etc.
Cover of the report Revenue forecast, company ranking, competitive landscape, growth factors and trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free customization of the report (equivalent to 8 working days for analysts) with purchase. Add or change the scope of country, region and segment.
Price and purchase options Take advantage of personalized shopping options to meet your exact research needs. Explore purchasing options

Regional Market Analysis AI-Based Medical Diagnostic Tools can be represented as follows:

Each regional sector of AI-based medical diagnostic tools is carefully studied to understand its current and future growth scenarios. It helps the players to strengthen their position. Use market research to gain a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global AI-based medical diagnostic tools market has segmented as follows:

  • North America includes the United States, Canada and Mexico
  • Europe includes Germany, France, UK, Italy, Spain
  • South America includes Colombia, Argentina, Nigeria and Chile
  • Asia-Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

Visualize the AI-Based Medical Diagnostic Tools Market Using Verified Market Intelligence: –

Verified Market Intelligence is our BI platform to tell the story of this market. VMI provides in-depth predictive trends and accurate insights into over 20,000 emerging and niche markets to help you make key revenue impact decisions for a bright future.

VMI provides a comprehensive overview and global competitive landscape of regions, countries, and segments, as well as key players in your market. Present your market reports and findings with built-in presentation capabilities, delivering over 70% of time and resources to investors, sales and marketing, R&D and product development. VMI supports data delivery in interactive Excel and PDF formats and provides over 15 key market indicators for your market.

The study thoroughly explores the profiles of the major market players and their main financial aspects. This comprehensive business analysis report is useful for all new entrants and new entrants as they design their business strategies. This report covers the production, revenue, market share and growth rate of the AI-based medical diagnostic tools market for each key company, and covers the breakdown data (production, consumption, revenue, and market share). market) by regions, type and applications. Historical breakdown data of AI-based medical diagnostic tools from 2016 to 2020 and forecast to 2021-2029.

About Us: Market Research Intelligence

Market Research Intellect provides syndicated and personalized research reports to clients across various industries and organizations, in addition to the goal of providing personalized and in-depth research studies.

We talk about solutions for logical research, personalized consulting and data severity analysis across a range of industries including energy, technology, manufacturing and construction, chemicals and materials, food. and drinks. Etc. Our research studies help our clients make more data-driven decisions, admit push predictions, grossly capitalize on opportunities, and maximize efficiency by acting as their belt in crime to adopt a mention precise and indispensable without compromise.

After serving the pinnacle of over 5,000 customers, we have provided expertly behaving affirmation research facilities to over 100 global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:

Mr. Edwyne Fernandes

United States: +1 (650) -781-480
UK: +44 (753) -715-0008
APAC: +61 (488) -85-9400
US Toll Free: +1 (800) -782-1768

Website: –

Source link

Vijaya diagnostic center makes mixed debut, posts 2% premium on BSE and ESN

At 10:10 am, shares of Vijaya Diagnostic were trading 8.8% higher against BSE

Shares of Vijaya Diagnostic Center made a mixed debut on the stock exchanges. The shares of the diagnostic chain supported by Kedaara Capital listed at Rs 542.30 on BSE, a premium of 2.13% over the issue price of Rs 531 per share. On the NSE, shares opened at Rs 540, a premium of 1.69%. At 10:10 am, shares of Vijaya Diagnostic were trading at Rs 577, up 8.8%, on BSE and at Rs 576.25, up 8.5%, on BSE.

The public offering of Vijaya Diagnostic Center was entirely an offer to sell 35.69 million shares by existing shareholders and promoters, including Dr S Surenranath Reddy, Karakoram and Kedaara Capital Alternative Investment Fund – Kedaara Capital AIF I.

The public offering was subscribed 4.54 times. The segment of qualified institutional buyers was subscribed 13.07 times, non-institutional investors were subscribed 1.32 times and the share of retail investors was subscribed 1.09 times.

The Vijaya Diagnostic Center was promoted by Dr S Surendranath Reddy. It is one of the largest integrated diagnostic chains in South India, offering pathology and radiology testing services in 80 diagnostic centers and 11 reference laboratories in 13 towns and villages in Telangana, Andhra Pradesh. , NCR and Kolkata.

Edelweiss Financial Services, ICICI Securities, and Kotak Mahindra Capital are the primary maintainers of the public issue, while KFintech is the registrar of the issue.

Source link

Automotive Diagnostic Tools Market Size 2021, Trends, Share, Key Players Analysis, Growth Factors, Applications, Types, Outlook and Forecast 2028

Automotive Diagnostic Tools Market Size and Forecast

The global Automotive Diagnostic Tools market report offers in-depth industry-driven drivers, restraints, threats, and opportunities in the market. The report provides comprehensive information on current market dynamics and future trends. Automotive Diagnostic Tools Market report highlights the investment scenario, market share, size and competitive landscape of companies, these details will help buyers, firms, strategists and individuals to be drawn from best conclusions. The Automotive Diagnostic Tools Market report additionally mentions the gross productivity, income, value, cost, as well as utilities or imports. The Automotive Diagnostic Tools Market report also tracks the latest market dynamics like driving factors, restraining factors, and industry news like mergers, acquisitions, and investments.

The emergence of the COVID-19 pandemic has severely impacted the global economy. It, in turn, touched a wide range of industries. This causes huge losses for manufacturers. However, we will soon be able to combat this serious situation with perseverance. Our reports will help you find the right path to your business success.

Get | Download a sample copy with table of contents, graphics and list of figures @

The report covers the following key players in the Automotive Diagnostic Tools Market:

• Robert Bosch
• Continental
• Denso Corporation
• SPX Corp
• Softening
• Incorporated Hickok
• Actia
• Kpit Technologies

Automotive Diagnostic Tools Market Segment Analysis:

Automotive Diagnostic Tools Market report provides the future products, demand, development strategy, business prospects, opportunities, future plans, production and consumption professional analysis, industry as a whole, The analysis of the information presented in the report is based on the competitive landscape of the two historical also as the current growth state parameters resources. It includes the major players of the global Automotive Diagnostic Tools market covered in the report, the research scope, market segments by type, application, and forecast year.

Automotive Diagnostic Tools Market by Product

• Wheel alignment tester
• Digital battery tester
• Vehicle emissions test systems

Automotive Diagnostic Tools Market by Application

• Passenger cars
• Commercial vehicles

Get a discount on purchasing this report @

Automotive Diagnostic Tools Market Analysis and Outlook:

Global Automotive Diagnostic Tools Market In 2021, the global Automotive Diagnostic Tools market size was $ 1 million and is expected to reach $ 1 million by the end of 2028, with a CAGR of between 2021 and 2028 Scope and Size of Global Automotive Diagnostic Tools The Global Automotive Diagnostic Tools market is segmented by region (country), company, type and application. Players, stakeholders, and other participants of the Global Automotive Diagnostics Market will be able to gain the upper hand by utilizing the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2021-2028.

Scope of Automotive Diagnostic Tools Market Report

Report attribute Details
Market size available for years 2021 – 2028
Reference year considered 2021
Historical data 2015 – 2020
Forecast period 2021 – 2028
Quantitative units Revenue in millions of USD and CAGR from 2021 to 2028
Covered segments Types, applications, end users, etc.
Cover of the report Revenue forecast, company ranking, competitive landscape, growth factors and trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free customization of the report (equivalent to 8 working days for analysts) with purchase. Add or change the scope of country, region and segment.
Price and purchase options Take advantage of personalized shopping options to meet your exact research needs. Explore purchasing options

Analysis of the geographic market for automotive diagnostic tools:

This research study draws on multiple layers of data, including business analysis (industry trends), high-level market share analysis, supply chain analysis, and brief company profiles that, together, provide and analyze fundamental perspectives on the competitive landscape. Growth trends and segments of high growth companies, high growth countries, market forces, controls, market drivers, restrictions and market drivers, and constraints. It is the most recent study that includes a strategic assessment as well as an in-depth examination of the market plans, approaches, brands and manufacturing capabilities of the world’s leading industry leaders.

– North America (United States, Canada, Mexico)
– Europe (Great Britain, France, Germany, Spain, Italy, Central and Eastern Europe, CIS)
– Asia Pacific (China, Japan, South Korea, ASEAN, India, rest of Asia-Pacific)
– Latin America (Brazil, rest of LA)
– Middle East and Africa (Turkey, CCG, rest of Middle East)

For more information or a query or customization before purchasing, visit @

Visualize Automotive Diagnostic Tools Market Using Verified Market Intelligence: –

Verified Market Intelligence is our BI platform for narrative storytelling for this market. VMI offers in-depth forecasting trends and accurate insight into over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a holistic overview and global competitive landscape with regard to region, country and segment as well as the major players in your market. Present your market report and findings with a built-in presentation function, saving over 70% of your time and resources for investor arguments, sales and marketing, R&D and product development. VMI enables data delivery in interactive Excel and PDF formats with over 15+ key market indicators for your market.

Visualize the Automotive Diagnostic Tools Market Using VMI @

About us: verified market reports

Verified Market Reports is a leading global research and advisory firm serving more than 5,000 clients around the world. We provide advanced analytical research solutions while delivering insightful research studies.

We also provide insight into the analytics and strategic and growth data needed to achieve business goals and critical revenue decisions.

Our 250 analysts and SMEs offer a high level of expertise in data collection and governance using industry techniques to collect and analyze data on more than 25,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

Our research covers a multitude of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage, and more. Having served numerous Fortune 2000 organizations, we bring a rich and reliable experience that covers all kinds of research needs.

Contact us:

Mr. Edwyne Fernandes

United States: +1 (650) -781-480
UK: +44 (753) -715-0008
APAC: +61 (488) -85-9400
US Toll Free: +1 (800) -782-1768

E-mail: [email protected]

Website: –

Source link

The demand for PCR diagnostic technology to continue the upward trend in the molecular oncology diagnostics market, according to Fact.MR

The Molecular Diagnostics in Oncology market size is based on a triangulation methodology which is primarily based on experimental modeling approaches such as patient-level data or disease epidemiology for all key indications, number of procedures and analysis of the installation base for any equipment in order to obtain accurate market estimates for the base year as well as in the analysis of historical data. A bottom-up approach is always used to obtain relevant molecular diagnostic data in oncology for specific countries / regions. Country-specific data is re-analyzed to derive data at the global level. Specific factors / parameters are considered to be related to the individual oncology molecular diagnostics market and quantified with insightful rationale.

A comprehensive estimate of the molecular diagnostics in oncology market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the Molecular diagnostics sales in oncology during the forecast period. The comparison of prices by region with the world average price is also taken into account in the study.

Click here for a sample report (including full table of contents, table and figures): –

Key segments covered by molecular diagnostics industry research in oncology

  • By product

    • Molecular diagnostic reagents and kits in oncology
    • Molecular diagnostic instruments in oncology
      • Molecular diagnostic table instruments in oncology
      • Portable and PoC instruments for molecular diagnostics in oncology
    • Molecular diagnostic software and services in oncology
  • By technology

    • Polymerase chain reaction (PCR) in oncology Molecular diagnostics
    • Isothermal nucleic acid amplification technology (INAAT) for molecular diagnostics in oncology
    • DNA sequencing and next-generation sequencing (NGS) for molecular diagnostics in oncology
    • In situ hybridization (ISH) technology for molecular diagnostics in oncology
    • DNA microarrays and DNA microarrays for molecular diagnostics in oncology
  • By end user

    • Molecular diagnostics in oncology used in diagnostic laboratories
    • Molecular diagnostics in oncology used in hospitals and clinics

Analysts have used many leading industry-wide business intelligence tools to consolidate market facts, figures and data into revenue estimates and projections in Market Insights of Oncology Molecular Diagnostic.

Major market stakeholders including industry players, policy makers and investors from various countries have continuously realigned their strategies and approaches to implement them in order to take advantage of new opportunities.

Need more information on the reporting methodology? Click here:-

Key points of the market research

  • The global molecular diagnostics in oncology market is expected to grow 2.3 times in value by 2031.
  • The demand for reagents and kits will increase at a CAGR of 12.8% over the next ten years.
  • The Chinese market is expected to reach a valuation of US $ 670 million by 2031.
  • The markets in Japan and Canada are expected to grow 8% and 9%, respectively.
  • The demand for PCR diagnostic technology will dominate the market over the next ten years.

The key parameters analyzed during the estimation of the molecular diagnostics in oncology market include:

  • Analyze Drugs / Therapeutic Field in Oncology Molecular Diagnosis:Overall population by age group / prevalence or incidence of any disease / treatment seeking rate / dosing regimen / average duration of treatment / overall cost of treatment and reimbursement are taken into account.
  • To analyze consumables for molecular diagnostics in oncology:

Overall population / disease prevalence or incidence / treatment request rate / average duration of treatment / average number of devices used per patient / average number of procedures per device / average selling price per device / reimbursement are taken into account.

  • To analyze molecular diagnostic equipment in oncology:

Number of health facilities (hospitals / outpatient surgical centers / clinics, etc.)

The average number of devices installed per installation / device lifespan / equipment replacement rate / new equipment sales per year / average sales price per equipment are taken into account.

Some of the insights and estimates of Molecular Oncology Diagnostics Market that makes this study unique in approach and effective in guiding stakeholders in understanding growth dynamics. The study provides:

  • Details regarding the latest innovations and developments in molecular diagnostics in oncology and how it is gaining popularity with customers during the forecast period.
  • Analysis of customer demand for products and how it is likely to evolve in the years to come.
  • Latest regulations enforced by government agencies and local agencies and their impact on oncology molecular diagnostics market demand.
  • Information on the adoption of new technologies and its influence on the size of the Molecular Diagnostics in Oncology market.
  • Overview of the impact of COVID-19 on the molecular oncology diagnostics market and the economic disruption caused by the pandemic.
  • Assesses the post-pandemic impact on Molecular Oncology Diagnostics market sales during the forecast period.

To Get Complete Insights on the Regional Landscape of Molecular Diagnostics in Oncology Market, Purchase Now: –

Competitive landscape

Leading oncology molecular diagnostic service providers, in an attempt to achieve stability, are adopting strategies such as specialty product development. The main players in the molecular diagnostics in oncology market are also entering into collaborations with the main brands of molecular diagnostic instruments in oncology, for the development of companion diagnostics relating to cancer.

Some of the key developments are:

  • In September 2015; Roche has launched the Cobas EGFR v2 mutation assay, used for the diagnosis of non-small cell lung cancer (NSCLC), which is expected to drive the growth of this market.
  • Qiagen and Lilly announced their intention to jointly develop companion diagnostics to target cancer biomarkers.
  • In February 2019, ICON plc, a US-based biotechnology company, acquired MolecularMD for an undisclosed amount. The acquisition enhances ICON’s laboratory offering in molecular diagnostic testing and provides ICON with extensive test platforms, including next-generation sequencing and immunohistochemistry (IHC).

Read more trend reports from Fact.MR: –

How Fact.MR helps take strategic action for the Molecular Oncology Diagnostics Market Manufacturer?

  • The data provided in the Molecular Oncology Diagnostics market report offers a comprehensive analysis of significant industry trends. Industry players can use this data to strategize their potential trade movements and generate remarkable revenue over the coming period.
  • The report covers price trend analysis and value chain analysis as well as the analysis of the diverse supply of market players. The primary motive for this report is to help companies make data-driven decisions and strategize for their trade movements.

More related reports by Fact.MR on Health sector :

Veterinary endodontics market : _Forecast, trend analysis and competition monitoring – Global review 2021 to 2031

Therapeutic Support Surfaces Market: – Forecasts, trend analysis and monitoring of the competition – Global review 2021 to 2031

Computer Assisted Orthopedic Surgery Market : – Forecasts, trend analysis and monitoring of the competition – Global review 2021 to 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1000 companies trust us to make their most critical decisions. We have offices in the United States and Dublin, while our global headquarters are in Dubai. While our experienced consultants use the latest technology to extract hard-to-find information, we believe our USP is the trust clients have in our expertise. Covering a wide spectrum – from automotive and industry 4.0 to healthcare and retail, our coverage is extensive, but we make sure that even the most specialized categories are analyzed. Contact us with your goals, and we will be a competent research partner.

US Sales Office:
11140 Rockville Pike
Office 400
Rockville, Maryland 20852
United States
Phone. : +1 (628) 251-1583
E-mail: [email protected]

The head office:
Unit No .: AU-01-H Gold Tower (AU),
Plot number: JLT-PH1-I3A,
Jumeirah Lakes Tours,
Dubai, United Arab Emirates

Visit our website:

The post office The demand for PCR diagnostic technology to continue the upward trend in the molecular oncology diagnostics market, according to Fact.MR appeared first on Latest market reports.

Source link